Pinnacle Wealth Management Group, Inc. Viking Therapeutics, Inc. Transaction History
Pinnacle Wealth Management Group, Inc.
- $163 Million
- Q3 2025
A detailed history of Pinnacle Wealth Management Group, Inc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Pinnacle Wealth Management Group, Inc. holds 9,565 shares of VKTX stock, worth $380,687. This represents 0.15% of its overall portfolio holdings.
Number of Shares
9,565Holding current value
$380,687% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
437Shares Held
66.7MCall Options Held
7.21MPut Options Held
3.87M-
Vanguard Group Inc Valley Forge, PA10MShares$398 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$240 Million0.01% of portfolio
-
State Street Corp Boston, MA4.51MShares$180 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.73MShares$148 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.58MShares$103 Million0.0% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.05B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...